Skip to main
  1. Stocks
  2. Janus Living Inc
  3. Forecast
JAN

JAN Stock Forecast & Price Target

JAN Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 71%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Janus Living is favorably positioned as the only U.S. publicly traded REIT fully owned and operated under RIDEA structures, giving it direct exposure to a strong senior housing backdrop and the ability to capture outsized operating gains through SHOP and life plan communities. Its growth case is reinforced by aggressive, accretive capital deployment, including about $1.1 billion of new acquisitions since the IPO, roughly $558 million of cash on hand, and an expected $1 billion forward investment pace that could add about $0.07/share, or roughly 6.0%, to the earnings run-rate. With FFO estimates rising to $0.98/share in 2026, $1.20/share in 2027, and $1.43/share in 2028, plus low net debt and improving returns on deals sourced at low-6.0% initial yields and potentially 7.5% or better by year 3, the company appears well set for strong accretive growth.

Bears say

Janus Living is vulnerable to a compressed risk/reward profile because its 2027E AFFO valuation already appears stretched at 21x and a 43% premium to NAV, leaving limited room for disappointment if senior housing fundamentals merely plateau. The negative view is reinforced by downside assumptions that life plan sales weaken, the recently transitioned portfolio only delivers average growth, and cautious capital deployment trims 4Q27-3Q28 AFFO by about 10%, while volatile cash NREFs can make earnings quality less predictable. In addition, limited free float, external management concerns, and exposure to regulatory, reimbursement, interest rate, and supply risks could pressure sentiment and amplify downside if the broader economy slows.

JAN has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 71% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Janus Living Inc and is not a guaranteed prediction by Public.com or investment advice.

JAN Analyst Forecast & Price Prediction

Get the latest JAN stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in JAN

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Janus Living Inc (JAN) Forecast

Analysts have given JAN a Buy based on their latest research and market trends.

According to 14 analysts, JAN has a Buy consensus rating as of Nov 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $32.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $32.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Janus Living Inc (JAN)


JAN Analyst Forecast & Price Prediction

Get the latest JAN stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in JAN

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover JAN stock data and trends